Page last updated: 2024-10-30

kynurenic acid and Rocky Mountain Spotted Fever

kynurenic acid has been researched along with Rocky Mountain Spotted Fever in 2 studies

Kynurenic Acid: A broad-spectrum excitatory amino acid antagonist used as a research tool.
kynurenic acid : A quinolinemonocarboxylic acid that is quinoline-2-carboxylic acid substituted by a hydroxy group at C-4.

Rocky Mountain Spotted Fever: An acute febrile illness caused by RICKETTSIA RICKETTSII. It is transmitted to humans by bites of infected ticks and occurs only in North and South America. Characteristics include a sudden onset with headache and chills and fever lasting about two to three weeks. A cutaneous rash commonly appears on the extremities and trunk about the fourth day of illness.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rapoport, MI2
Beisel, WR2
Hornick, RB1

Trials

1 trial available for kynurenic acid and Rocky Mountain Spotted Fever

ArticleYear
Tryptophan metabolism during infectious illness in man.
    The Journal of infectious diseases, 1970, Volume: 122, Issue:3

    Topics: Administration, Oral; Adult; Aminohippuric Acids; Clinical Trials as Topic; Diazonium Compounds; Hum

1970

Other Studies

1 other study available for kynurenic acid and Rocky Mountain Spotted Fever

ArticleYear
Studies of tryptophan metabolism in experimental animals and man during infectious illness.
    The American journal of clinical nutrition, 1971, Volume: 24, Issue:7

    Topics: Adrenal Glands; Adrenalectomy; Amino Acids; Aminohippuric Acids; Animals; Azo Compounds; Carbon Isot

1971